Unichem Labs gets tentative USFDA nod for erectile dysfunction treatment tablets
New Delhi: Drug firm Unichem Laboratories recently said it has received a tentative nod from the US health regulator for generic Tadalafil tablets used for the treatment of erectile dysfunction.
The company has received the tentative approval from the United States Food and Drug Administration for its Tadalafil tablets in the strengths of 2.5 mg, 5 mg, 10 mg and 20 mg, Unichem Laboratories said in a filing to the BSE.
The tablets are used for the treatment of erectile dysfunction, signs and symptoms of benign prostatic hyperplasia and ED/BPH, Unichem Laboratories added.
The product is a generic version of Eli Lilly's Cialis tablets in the same strengths, it added.
Unichem Laboratories is a pharmaceutical company headquartered in Mumbai.
Read Also: Unichem gets EIR from USFDA for Pithampur, Roha facilities
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd